PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma
Study sponsor: Soligenix
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-08-16Actual
Enrollment · participants9Actual
Source updated2023-06-07Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.